Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Sectoral/ Thematic median (248 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 19 Mar 2026 – 20 Aug 2026, limited by LIC MF Technology Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | LIC MF Technology Fund | Nifty 500 |
|---|---|---|
| 19 Mar 2026 | ₹100.00 | ₹100.00 |
| 01 Apr 2026 | ₹100.16 | ₹98.63 |
| 14 Apr 2026 | ₹102.96 | ₹104.49 |
| 27 Apr 2026 | ₹103.32 | ₹107.52 |
| 09 May 2026 | ₹105.40 | ₹108.90 |
| 22 May 2026 | ₹106.29 | ₹106.72 |
| 04 Jun 2026 | ₹106.19 | ₹105.99 |
| 17 Jun 2026 | ₹107.24 | ₹108.88 |
| 30 Jun 2026 | ₹104.31 | ₹108.34 |
| 13 Jul 2026 | ₹108.69 | ₹109.99 |
| 25 Jul 2026 | ₹106.34 | ₹107.95 |
| 07 Aug 2026 | ₹112.97 | ₹111.71 |
| 20 Aug 2026 | ₹113.31 | ₹110.78 |
| Metric | LIC · Regular · IDCW NAV ₹11.34 Very High risk Unrated | Category median Sectoral/ Thematic · 248 funds |
|---|---|---|
| — | +3.54% | |
| — | +11.47% | |
| — | +9.70% | |
| — | +10.32% | |
| +13.31% | +9.15% | |
| +32.79% | — | |
| — | +12.10% | |
| — | +10.32% | |
| — | +8.80% | |
| Risk | ||
| 12.87% | 15.91% | |
| — | 0.25 | |
| — | 0.32 | |
| -4.98% | -26.14% | |
| Nifty 500 | — | |
| — | -0.04% | |
| — | 0.98 | |
| — | 98.3% | |
| — | 101.5% | |
| 2.81% | 2.38% | |
| ₹83.56Cr | ₹1,160Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹200 | — | |
| ₹1.00K | — | |
| — | 42% | |
| Karan Doshi | — | |
| 19 Mar 2026 | — | |
| 30 | — | |
| 46.4% | — | |
| 15.0% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.